1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid-d4;2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1-(phenyl-d4)-1’-phenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid; CV-11974-d4; Candesartan M1-d4; 3-[[2'-(1H-Tetrazol-5-yl)[1-(phenyl-d4)-1’-phenyl]-4-yl]methyl]-2-ethoxy-3H-benzimidazole-4-carboxylic Acid;
Candesartan-d4 is a fully characterized chemical compound used as a reference standard of API Candesartan. The standard offered is compliant with regulatory guidelines. Candesartan-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1346604-70-3
